Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fphar.2026.1942002.s001BackgroundThis study developed and validated an machine-learning-based radiomics model integrating tumor habitat radiomics, peritumoral radiomics, and clinical features to predict progression-free survival (PFS) following repeat transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).MethodsThis retrospective multicenter study included 270 patients with HCC. Patients from Center 1 were assigned to training (n = 94) and internal validation (n = 41) cohorts, while Centers 2 (n = 82) and 3 (n = 53) served as external validation cohorts. Tumor habitats and 5-mm peritumoral regions were generated from contrast-enhanced CT images. Radiomics features were selected using univariate Cox and LASSO-Cox regression. A fusion model and HPC risk score were constructed by integrating selected radiomics signatures and clinical variables. Performance was assessed using time-dependent ROC, C-index, calibration, decision curve analysis, and Kaplan–Meier analyses.ResultsThe optimal habitat cluster number was K = 2. Eleven habitat features, three peritumoral features, and alpha-fetoprotein were retained in the fusion model. The model achieved AUCs of 0.923, 0.921, and 0.897 for 3-, 6-, and 9-month progression-free survival in the training cohort, and 0.932, 0.863, and 0.916 in the internal validation cohort, respectively; all external AUCs exceeded 0.82. The fusion model showed higher C-index values than the clinical model across cohorts. High-risk patients had significantly shorter PFS than low-risk patients (all P ConclusionThe CT-based fusion model and HPC risk score effectively predicted progression risk in HCC.
Keyword(s):
artificial intelligence; habitat radiomics; hepatocellular carcinoma; peritumoral radiomics; Pharmacology.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)